Skip to search formSkip to main contentSkip to account menu

MammaPrint

Known as: Agendia 
MammaPrint is a diagnostic test to assess the risk that a breast tumor will metastasize to other parts of the body. This helps physicians determine… 
Wikipedia (opens in a new tab)

Related topics

Related topics

1 relation
Microarray

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
HEALTH EVIDENCE REVIEW COMMISSION (HERC) COVERAGE GUIDANCE: BIOMARKER TESTS OF CANCER TISSUE FOR PROGNOSIS AND POTENTIAL RESPONSE TO TREATMENT
  • 2015
  • Corpus ID: 46235270
Oncotype DX is recommended for coverage in early stage breast cancer when used to guide adjuvant chemotherapy treatment decisions… 
2014
2014
Aberto processo seletivo para monitoria na Agêndia Da Hora
2014
2014
EVALUAR LOS PERFILES DE EXPRESIÓN GENÉTICA CON LA PRUEBA MAMMAPRINT Y TARGET PRINT CON INMUNOHISTOQUÍMICA
SUMMARY OBJECTIVE: We show our experience with test of 70 genes (Mammaprint ® ), in evaluation and the treatment patients with… 
2014
2014
Comparisons of statistical methods for determining gene expression signatures to predict binary cancer response
OF THE DISSERTATIOIN .......................................................................... ii Acknowledgement… 
2013
2013
Experiencia en la Utilización del Perfil Genético de 70 Genes Mammaprint
SUMMARY OBJECTIVES: Prospective study to evaluate the technical usefulness of the platform 70-gene mammaprint gene, in order to… 
Review
2013
Review
2013
Genexpressionssignaturen beim Mammakarzinom
ZusammenfassungHintergrundGenexpressionssignaturen zeigen die molekulare Heterogenität des Mammakarzinoms. Die ersten… 
2012
2012
Les signatures moléculaires sur paraffine dans le cancer du sein : le point de vue du pathologiste
Oncology research, and particularly breast pathology, is undergoing a revolution with the advent of molecular signatures. These… 
2012
2012
BreastCare The 70-Gene Signature as Prognostic Factor for Elderly Women with Hormone Receptor-Positive , HER 2-Negative Breast Cancer
Zusammenfassung Hintergrund: Ziel dieser Arbeit war die Evaluierung der 70-Gen-Prognose-Signatur Mammaprint bei Patientinnen ≥ 60… 
2011
2011
Experiencia en la utilización del mammaprint en la Clínica de mamas de Barquisimeto
The objective of this work was information of genetic characteristics of tumor, determined by methods such as mamma print… 
Review
2009
Review
2009
Imaging , Diagnosis , Prognosis Microarray-Based Determination of Estrogen Receptor , Progesterone Receptor , and HER 2 Receptor Status in Breast Cancer
Purpose: The level of estrogen receptor (ER), progesterone receptor (PR), and HER2 aids in the determination of prognosis and… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)